2016 US lymphoid malignancy statistics by World Health Organization subtypesLauren R. Teras, Christopher R. Flowers, Carol DeSantis et al.|CA A Cancer Journal for Clinicians|2016Cited by 1.1k
Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline UpdateRandy Taplitz, Christopher R. Flowers, Erin B. Kennedy et al.|Journal of Clinical Oncology|2018Cited by 574
Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trialDavid Marín, Katayoun Rezvani, Ye Li et al.|Nature Medicine|2024Cited by 452
Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline UpdateRandy Taplitz, Christopher R. Flowers, Jennie R. Crews et al.|Journal of Clinical Oncology|2018Cited by 405
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapyChristoph K. Stein‐Thoeringer, Eran Elinav, Neeraj Saini et al.|Nature Medicine|2023Cited by 226